Literature DB >> 32748768

Case Report: Unusual Presentation of Pharyngeal Mucosal Leishmaniasis due to Leishmania (Viannia) braziliensis.

Lorena Pinheiro Figueiredo1,2, Laiana do Carmo Almeida3, Andréa Magalhães1, Sérgio Arruda4, Marcus M Lessa1,2,3, Edgar M Carvalho1,4.   

Abstract

Mucosal leishmaniasis (ML) affects predominantly the nose and occurs usually weeks or months after the cure of the primary cutaneous lesion. The pathology of ML is characterized by an exaggerated inflammatory reaction with infiltration of lymphocytes, macrophages, and plasma cells. There is also a paucity of parasites and a strong delayed-type hypersensitivity reaction. Herein, we report a case of a young man who had a large ulcer in his left leg and complained of dysphagia. In nasofibrolaryngoscopy, there were nodular lesions in the oropharynx and rhinopharynx. The skin lesion biopsy showed a chronic inflammation with amastigotes inside macrophages, and DNA of Leishmania braziliensis confirmed the diagnosis of ML in tissue biopsied from the pharynx. The leishmaniasis skin test was negative. Cytokine evaluation showed lack of production of interferon (IFN)-γ, interleukin (IL)-1β, and IL-17 with enhancement of these cytokine levels after cure.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32748768      PMCID: PMC7543809          DOI: 10.4269/ajtmh.20-0219

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  20 in total

1.  Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy.

Authors:  Estrella Garcia-Gonzalez; Giacomo M Guidelli; Marco Bardelli; Roberta Maggio
Journal:  Rheumatology (Oxford)       Date:  2012-03-15       Impact factor: 7.580

Review 2.  Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature.

Authors:  Alba Català; Esther Roé; Joan Dalmau; Virginia Pomar; Carme Muñoz; Oriol Yelamos; Luis Puig
Journal:  Dermatology       Date:  2015-01-23       Impact factor: 5.366

Review 3.  Mucosal leishmaniasis ("espundia" Escomel, 1911).

Authors:  P D Marsden
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

4.  Up-regulation of Th1-type responses in mucosal leishmaniasis patients.

Authors:  Olívia Bacellar; Hélio Lessa; Albert Schriefer; Paulo Machado; Amélia Ribeiro de Jesus; Walderez O Dutra; Kenneth J Gollob; Edgar M Carvalho
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples.

Authors:  Jason L Weirather; Selma M B Jeronimo; Shalini Gautam; Shyam Sundar; Mitchell Kang; Melissa A Kurtz; Rashidul Haque; Albert Schriefer; Sinésio Talhari; Edgar M Carvalho; John E Donelson; Mary E Wilson
Journal:  J Clin Microbiol       Date:  2011-11       Impact factor: 5.948

6.  Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.

Authors:  Silvana C Silva; Luiz Henrique Guimarães; Juliana A Silva; Viviane Magalhães; Lilian Medina; Adriano Queiroz; Paulo Roberto L Machado; Albert Schriefer
Journal:  Acta Trop       Date:  2017-10-16       Impact factor: 3.112

7.  Association between an emerging disseminated form of leishmaniasis and Leishmania (Viannia) braziliensis strain polymorphisms.

Authors:  Adriano Queiroz; Rosana Sousa; Claudia Heine; Manuela Cardoso; Luiz Henrique Guimarães; Paulo Roberto Lima Machado; Edgar M Carvalho; Lee W Riley; Mary E Wilson; Albert Schriefer
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

8.  Cell mediated immunity in American cutaneous and mucosal leishmaniasis.

Authors:  E M Carvalho; W D Johnson; E Barreto; P D Marsden; J L Costa; S Reed; H Rocha
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.

Authors:  Fernanda O Novais; Augusto M Carvalho; Megan L Clark; Lucas P Carvalho; Daniel P Beiting; Igor E Brodsky; Edgar M Carvalho; Phillip Scott
Journal:  PLoS Pathog       Date:  2017-02-13       Impact factor: 6.823

Review 10.  Mucosal leishmaniasis: epidemiological and clinical aspects.

Authors:  Marcus Miranda Lessa; Hélio Andrade Lessa; Thomas W N Castro; Adja Oliveira; Albert Scherifer; Paulo Machado; Edgar M Carvalho
Journal:  Braz J Otorhinolaryngol       Date:  2007 Nov-Dec
View more
  1 in total

Review 1.  Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?

Authors:  Debora B Scariot; Austeja Staneviciute; Jennifer Zhu; Xiaomo Li; Evan A Scott; David M Engman
Journal:  Front Cell Infect Microbiol       Date:  2022-09-16       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.